SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling

Scott B Biering; Francielle Tramontini Gomes de Sousa; Laurentia V. Tjang; Felix Pahmeier; Richard Ruan; Sophie F. Blanc; Trishna S. Patel; Caroline M. Worthington; Dustin R. Glasner; Bryan Castillo-Rojas; Venice Servellita; Nicholas TN Lo; Marcus P Wong; Colin M. Warnes; Daniel R. Sandoval; Thomas Mandel Clausen; Yale A. Santos; Victoria Ortega; Hector Aguilar-Carreno; Jeffrey D Esko; Charles Y Chiu; John E. Pak; P. Robert Beatty; Eva Harris.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-472112

Documentos relacionados

  1. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-ß signaling.
  2. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-ß signaling.
  3. Myeloid dysregulation and therapeutic intervention in COVID-19.
  4. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  5. Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.
  6. Diverse roles of SARS-CoV-2 Spike and Nucleocapsid proteins in EndMT stimulation through the TGF-ß-MRTF axis inhibited by aspirin.
  7. Untimely TGFß responses in COVID-19 limit antiviral functions of NK cells.
  8. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.
  9. The SARS-CoV-2 E protein induces Toll-like receptor 2-mediated neonatal lung injury in a model of COVID-19 viremia that is rescued by the glucocorticoid ciclesonide.
  10. Mechanisms of SARS-CoV-2 entry into cells.